CRBU insider transactions
Caribou Biosciences Inc. (CRBU) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.
Recent Form 3, 4, and 5 filings for CRBU
- Chief Technology Officer Kelly Timothy P sold $12,020 worth of shares (6,228 units at $1.93), decreasing direct ownership by 8% to 73,125 units (SEC Form 4)4 - Caribou Biosciences, Inc. (0001619856) (Issuer)
- Chief Technology Officer Kelly Timothy P was granted 45,000 shares and sold $6,168 worth of shares (3,147 units at $1.96), increasing direct ownership by 112% to 79,353 units (SEC Form 4)4 - Caribou Biosciences, Inc. (0001619856) (Issuer)
- Chief Legal Officer Mcclung Barbara G was granted 45,000 shares and sold $13,598 worth of shares (6,938 units at $1.96), increasing direct ownership by 9% to 481,564 units (SEC Form 4)4 - Caribou Biosciences, Inc. (0001619856) (Issuer)
- Chief Business Officer Khan Ruhi Ahmad was granted 45,000 shares and sold $13,598 worth of shares (6,938 units at $1.96), increasing direct ownership by 57% to 104,998 units (SEC Form 4)4 - Caribou Biosciences, Inc. (0001619856) (Issuer)
- Chief Medical Officer Albertson Tina M. was granted 55,000 shares and sold $2,089 worth of shares (1,066 units at $1.96), increasing direct ownership by 370% to 68,523 units (SEC Form 4)4 - Caribou Biosciences, Inc. (0001619856) (Issuer)
- SEC Form 4 filed by Director Richardson-Heron Dara4 - Caribou Biosciences, Inc. (0001619856) (Issuer)
- SEC Form 4 filed by Director Johnson David Lee4 - Caribou Biosciences, Inc. (0001619856) (Issuer)
- SEC Form 4 filed by Director Sacks Natalie4 - Caribou Biosciences, Inc. (0001619856) (Issuer)
- SEC Form 4 filed by Director Zheng Ran4 - Caribou Biosciences, Inc. (0001619856) (Issuer)
- SEC Form 4 filed by Director Whiting Nancy4 - Caribou Biosciences, Inc. (0001619856) (Issuer)
- SEC Form 4 filed by Director Guggenhime Andrew4 - Caribou Biosciences, Inc. (0001619856) (Issuer)
- SEC Form 4 filed by Director Braunstein Scott4 - Caribou Biosciences, Inc. (0001619856) (Issuer)
- Chief Financial Officer Ryali Sriram was granted 55,000 shares, increasing direct ownership by 317% to 72,360 units (SEC Form 4)4 - Caribou Biosciences, Inc. (0001619856) (Issuer)
- President and CEO Haurwitz Rachel E. was granted 151,700 shares, increasing direct ownership by 51% to 447,150 units (SEC Form 4)4 - Caribou Biosciences, Inc. (0001619856) (Issuer)
- President and CEO Haurwitz Rachel E. bought $20,400 worth of shares (20,000 units at $1.02) (SEC Form 4)4 - Caribou Biosciences, Inc. (0001619856) (Issuer)
- President and CEO Haurwitz Rachel E. was granted 136,750 shares, increasing direct ownership by 86% to 295,450 units (SEC Form 4)4 - Caribou Biosciences, Inc. (0001619856) (Issuer)
- Chief Medical Officer Albertson Tina M. was granted 14,589 shares (SEC Form 4)4 - Caribou Biosciences, Inc. (0001619856) (Issuer)
- Chief Legal Officer Mcclung Barbara G was granted 37,500 shares and sold $4,811 worth of shares (3,564 units at $1.35), increasing direct ownership by 8% to 443,502 units (SEC Form 4)4 - Caribou Biosciences, Inc. (0001619856) (Issuer)
- Chief Business Officer Khan Ruhi Ahmad was granted 37,500 shares and sold $4,811 worth of shares (3,564 units at $1.35), increasing direct ownership by 103% to 66,936 units (SEC Form 4)4 - Caribou Biosciences, Inc. (0001619856) (Issuer)
- Chief Technology Officer Kelly Timothy P was granted 37,500 shares (SEC Form 4)4 - Caribou Biosciences, Inc. (0001619856) (Issuer)
- Chief Scientific Officer Kanner Steven was granted 37,500 shares and sold $4,811 worth of shares (3,564 units at $1.35), increasing direct ownership by 9% to 431,556 units (SEC Form 4)4 - Caribou Biosciences, Inc. (0001619856) (Issuer)
- SEC Form 4 filed by Director Zheng Ran4 - Caribou Biosciences, Inc. (0001619856) (Issuer)
- SEC Form 4 filed by Director Whiting Nancy4 - Caribou Biosciences, Inc. (0001619856) (Issuer)
- SEC Form 4 filed by Director Sacks Natalie4 - Caribou Biosciences, Inc. (0001619856) (Issuer)
- SEC Form 4 filed by Director Richardson-Heron Dara4 - Caribou Biosciences, Inc. (0001619856) (Issuer)
- SEC Form 4 filed by Director Johnson David Lee4 - Caribou Biosciences, Inc. (0001619856) (Issuer)
- SEC Form 4 filed by Director Guggenhime Andrew4 - Caribou Biosciences, Inc. (0001619856) (Issuer)
- SEC Form 4 filed by Director Braunstein Scott4 - Caribou Biosciences, Inc. (0001619856) (Issuer)
- Chief Financial Officer Ryali Sriram bought $24,651 worth of shares (17,360 units at $1.42) (SEC Form 4)4 - Caribou Biosciences, Inc. (0001619856) (Issuer)
- SEC Form 4 filed by Chief Financial Officer Ryali Sriram4 - Caribou Biosciences, Inc. (0001619856) (Issuer)
- SEC Form 3 filed by new insider Ryali Sriram3 - Caribou Biosciences, Inc. (0001619856) (Issuer)
- VP of Finance and Controller Fischesser Ryan was granted 25,000 shares, increasing direct ownership by 27% to 118,854 units (SEC Form 4)4 - Caribou Biosciences, Inc. (0001619856) (Issuer)
- New insider Fischesser Ryan claimed ownership of 93,854 shares (SEC Form 3)3 - Caribou Biosciences, Inc. (0001619856) (Issuer)
- SEC Form 4 filed by Chief Medical Officer Albertson Tina M.4 - Caribou Biosciences, Inc. (0001619856) (Issuer)
- SEC Form 3 filed by new insider Albertson Tina M.3 - Caribou Biosciences, Inc. (0001619856) (Issuer)
- O'Byrne Jason was granted 33,000 shares, increasing direct ownership by 126% to 59,224 units (SEC Form 4)4 - Caribou Biosciences, Inc. (0001619856) (Issuer)
- Mcclung Barbara G was granted 33,000 shares, increasing direct ownership by 9% to 409,566 units (SEC Form 4)4 - Caribou Biosciences, Inc. (0001619856) (Issuer)
- Khan Ruhi Ahmad was granted 33,000 shares (SEC Form 4)4 - Caribou Biosciences, Inc. (0001619856) (Issuer)
- Haurwitz Rachel E. was granted 118,700 shares, increasing direct ownership by 297% to 158,700 units (SEC Form 4)4 - Caribou Biosciences, Inc. (0001619856) (Issuer)
- Kanner Steven was granted 33,000 shares, increasing direct ownership by 9% to 387,037 units (SEC Form 4)4 - Caribou Biosciences, Inc. (0001619856) (Issuer)
- SEC Form 4 filed by Zheng Ran4 - Caribou Biosciences, Inc. (0001619856) (Issuer)
- SEC Form 4 filed by Whiting Nancy4 - Caribou Biosciences, Inc. (0001619856) (Issuer)
- SEC Form 4 filed by Sacks Natalie4 - Caribou Biosciences, Inc. (0001619856) (Issuer)
- SEC Form 4 filed by Richardson-Heron Dara4 - Caribou Biosciences, Inc. (0001619856) (Issuer)
- SEC Form 4 filed by Johnson David Lee4 - Caribou Biosciences, Inc. (0001619856) (Issuer)
- SEC Form 4 filed by Guggenhime Andrew4 - Caribou Biosciences, Inc. (0001619856) (Issuer)
- SEC Form 4 filed by Braunstein Scott4 - Caribou Biosciences, Inc. (0001619856) (Issuer)
- Kanner Steven exercised 30,577 shares at a strike of $2.69, increasing direct ownership by 9% to 354,037 units (SEC Form 4)4 - Caribou Biosciences, Inc. (0001619856) (Issuer)
- SEC Form 3 filed by new insider Kelly Timothy P (Amendment)3/A - Caribou Biosciences, Inc. (0001619856) (Issuer)
- SEC Form 4 filed by Kelly Timothy P4 - Caribou Biosciences, Inc. (0001619856) (Issuer)
- SEC Form 3 filed by new insider Kelly Timothy P3 - Caribou Biosciences, Inc. (0001619856) (Issuer)
- SEC Form 4 filed by Haurwitz Rachel E.4 - Caribou Biosciences, Inc. (0001619856) (Issuer)
- SEC Form 4 filed by Haurwitz Rachel E.4 - Caribou Biosciences, Inc. (0001619856) (Issuer)
- SEC Form 4 filed by Richardson-Heron Dara4 - Caribou Biosciences, Inc. (0001619856) (Issuer)
- SEC Form 4 filed by Haurwitz Rachel E.4 - Caribou Biosciences, Inc. (0001619856) (Issuer)
- SEC Form 4 filed by Kanner Steven4 - Caribou Biosciences, Inc. (0001619856) (Issuer)
- SEC Form 4 filed by Sacks Natalie4 - Caribou Biosciences, Inc. (0001619856) (Issuer)
- SEC Form 4 filed by Khan Ruhi Ahmad4 - Caribou Biosciences, Inc. (0001619856) (Issuer)
- SEC Form 4 filed by Rizvi Syed Ali-Aamir4 - Caribou Biosciences, Inc. (0001619856) (Issuer)
- SEC Form 4 filed by Zheng Ran4 - Caribou Biosciences, Inc. (0001619856) (Issuer)